Dr. Perry Robins, JDD Editor-in-Chief and Mohs Surgery Pioneer, Joins Emerald Medical Applications
Emerald Medical Applications Corp., the Israeli-based company engaged in the development and sale of DermaCompare, its
proprietary artificial intelligence technology and application for the early diagnosis of melanoma and other skin cancers, announced
that Dr. Perry Robins has joined the Company's Medical Advisory Board.
Dr. Robins is Professor Emeritus of Dermatology and was Chief of the Mohs Micrographic Surgery Unit at New York University
Medical Center for over forty years. He has performed more than 47,000 Mohs surgical procedures, and trained doctors from around
the world. He is also the Founder and President of The Skin Cancer Foundation, an international organization dedicated to skin
cancer awareness, research, and public and medical education.
